Showing results (301-310 of 319) with videos related to

Sort By:
Pageof 32
Scientific Reports|August 30, 2024
Impact of metformin, statin, aspirin and insulin on the prognosis of uHCC patients receiving first line Lenvatinib or Atezolizumab plus BevacizumabMargherita Rimini, Margarida Montes, Elisabeth Amadeo, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 11, 2020
Measurement of Gamma Glutamyl Transferase to Determine Risk of Liver Transplantation or Death in Patients With Primary Biliary CholangitisAlessio Gerussi, Davide Paolo Bernasconi, Sarah Elisabeth O'Donnell, et al.
Hepatology (Baltimore, Md.)|July 27, 2018
Restaging Patients With Hepatocellular Carcinoma Before Additional Treatment Decisions: A Multicenter Cohort StudyAlessandro Vitale, Fabio Farinati, Giulia Noaro, et al.
Liver Cancer|May 16, 2024
Incidence and Predictors of Esophagogastric Varices Bleeding in Patients with Hepatocellular Carcinoma in LenvatinibMassimo Iavarone, Eleonora Alimenti, Toshifumi Tada, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 26, 2026
Predicting decompensation in unresectable hepatocellular carcinoma on atezolizumab plus bevacizumab: the ARTE ScoreLorenzo Canova, Eleonora Alimenti, Lorenzo Argiento, et al.
The Lancet. Gastroenterology & Hepatology|July 19, 2018
Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response ScoreMarco Carbone, Alessandra Nardi, Steve Flack, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 27, 2023
Quality of life in liver transplant recipients during the Corona virus disease 19 pandemic: A multicentre studyStefano Gitto, Lucia Golfieri, Nicolò Mannelli, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 6, 2022
Predictors of serious adverse events and non-response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acidAntonio De Vincentis, Daphne D'Amato, Laura Cristoferi, et al.
European Journal of Cancer (Oxford, England : 1990)|June 29, 2023
Sequential therapies after atezolizumab plus bevacizumab or lenvatinib first-line treatments in hepatocellular carcinoma patientsMara Persano, Margherita Rimini, Toshifumi Tada, et al.
Nature Genetics|July 20, 2010
Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosisXiangdong Liu, Pietro Invernizzi, Yue Lu, et al.
Pageof 32